D-0898-2018 Class II Terminated
FDA drug recall D-0898-2018 was initiated by SCA Pharmaceuticals, LLC on Jun 14, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage. The recall status is terminated (terminated Feb 4, 2019). Affected quantity: 2,268 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 11, 2018
- Initiation Date
- Jun 14, 2018
- Termination Date
- Feb 4, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,268 bags
Product Description
Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT
Reason for Recall
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Distribution Pattern
Product was distributed throughout the United States.
Code Information
Lot # 1218000928, 1218000944, 1218000945, 1218001075, 1218001076, 1218001188, Exp 06/19/2018-07/03/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0898-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026